News - Page 208 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article ATMA Launches Canada’s First Psychedelic Training Program for Mental Health Professionals that Includes a Legal Psychedelic Experience

ATMA Launches Canada’s First Psychedelic Training Program for Mental Health Professionals that Includes a Legal Psychedelic Experience

Post published:February 12, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: DMT for Stroke; MindMed’s Drug Discovery Partnership; Psychedelics are in Vogue

Psychedelic Bulletin: DMT for Stroke; MindMed’s Drug Discovery Partnership; Psychedelics are in Vogue

Post published:February 12, 2021
Post category:Psychedelic Bulletin

Read more about the article MINDCURE Announces Listing of Warrants

MINDCURE Announces Listing of Warrants

Post published:February 11, 2021
Post category:Press Release

Read more about the article PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

Post published:February 11, 2021
Post category:Press Release

Read more about the article Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

Nova Mentis Appoints Gary R. Harlem to Scientific Advisory Board

Post published:February 11, 2021
Post category:Press Release

Read more about the article MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

Post published:February 11, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

Tryp Therapeutics Appoints Dr. Joel Castellanos as Clinical Advisor

Post published:February 11, 2021
Post category:Press Release

Read more about the article Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Post published:February 10, 2021
Post category:Press Release

Read more about the article Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Mind Cure Announces Closing of $23 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Post published:February 10, 2021
Post category:Press Release

Read more about the article Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

Post published:February 10, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.